Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging

Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging - A Randomized Controlled Double Blind Study

Status

UNKNOWN

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02877758

Acronym

REDUCEAGE

Enrollment

Registered

2016-08-24

Start date

2016-09-30

Completion date

2017-02-28

Last updated

2016-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

cutaneous aging, skin rejuvenation, wrinkles

Brief summary

Tomorrowlabs has developed a revolutionary cosmeceutical formulation to rejuvenate aging skin. Tomorrowlabs is conducting this research to study whether this cosmeceutical can reduce the visible signs of cutaneous aging.

Detailed description

It is proposed to study a cosmeceutical formulation designed to reduce the visible signs of cutaneous aging. It is expected that daily application of the formulation may minimize wrinkles and fine lines of the face.

Interventions

OTHERTomorrowlabs cosmeceutical formulation

OTHERSham cosmeceutical formulation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

30 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy volunteers who desire to improve their appearance by reducing the visible signs of cutaneous aging in the face

Exclusion criteria

* Subjects who have undergone facial plastic surgery or aesthetic dermatology treatments to the face (such as fillers and neuromodulators) in the past 6 months * Subjects with a history of collagen vascular disease, cutis laxa, connective tissue disease, psoriasis, or lupus. * Subjects diagnosed with scleroderma. * Subjects with a body mass index (BMI) \> 30. * Subjects taking steroid therapy.

Design outcomes

Primary

Measure	Time frame	Description
Validated Assessment Scales for Age-related Changes of the Face	3 months	A reliable tool for valid and reproducible assessment of the aging process in various face areas will be employed by our independent panel of assessors to scale the primary outcome. (1-3)

Secondary

Measure	Time frame	Description
Skin quality assessment	3 months	The skin scope uses black light and magnification to show variety of skin imperfections that are undetectable with the naked eye such as dry and thin skin
Subject Satisfaction With the Results	3 months	Self assessment questionnaire

Contacts

Primary ContactDominik Thor, PhD

dominik@thor.at+4369911917515

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026